"Anti-Dyskinesia Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.
| Descriptor ID |
D018726
|
| MeSH Number(s) |
D27.505.954.427.090
|
| Concept/Terms |
Anti-Dyskinesia Agents- Anti-Dyskinesia Agents
- Agents, Anti-Dyskinesia
- Anti Dyskinesia Agents
- Movement Disorder Agents
- Agents, Movement Disorder
- Disorder Agents, Movement
|
Below are MeSH descriptors whose meaning is more general than "Anti-Dyskinesia Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Dyskinesia Agents".
This graph shows the total number of publications written about "Anti-Dyskinesia Agents" by people in this website by year, and whether "Anti-Dyskinesia Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Dyskinesia Agents" by people in Profiles.
-
Chorea-ballism as a dominant clinical manifestation in heteroplasmic mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation in mitochondrial genome: a case report. J Med Case Rep. 2019 Mar 06; 13(1):63.
-
Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dtsz) hamster and moderate antidystonic efficacy of M1 and M4 anticholinergics. Neuroscience. 2017 08 15; 357:84-98.